End-of-day quote
Korea S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
8,880
KRW
|
-1.55%
|
|
+2.66%
|
-1.44%
|
Apr. 26 |
ICD Co., Ltd. announced that it has received KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Kiwoomfni Co., Ltd., Shinhan Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd.
|
CI
| 2023 |
ICD Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
|
CI
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
108,237
|
323,974
|
309,555
|
214,496
|
140,168
|
145,979
|
Enterprise Value (EV)
1 |
132,378
|
322,758
|
263,135
|
162,752
|
123,725
|
133,360
|
P/E ratio
|
3.8
x
|
28
x
|
9.27
x
|
286
x
|
-26.2
x
|
-3.88
x
|
Yield
|
2.23%
|
0.76%
|
1.91%
|
1.56%
|
1.13%
|
-
|
Capitalization / Revenue
|
0.46
x
|
2.66
x
|
1
x
|
1.85
x
|
0.93
x
|
2.34
x
|
EV / Revenue
|
0.57
x
|
2.65
x
|
0.85
x
|
1.41
x
|
0.82
x
|
2.14
x
|
EV / EBITDA
|
2.89
x
|
15.6
x
|
4.63
x
|
18.6
x
|
86
x
|
-4.4
x
|
EV / FCF
|
3.68
x
|
16.8
x
|
3.76
x
|
6.89
x
|
-3.54
x
|
-17.1
x
|
FCF Yield
|
27.2%
|
5.95%
|
26.6%
|
14.5%
|
-28.2%
|
-5.86%
|
Price to Book
|
0.81
x
|
2.2
x
|
1.72
x
|
1.25
x
|
0.91
x
|
1.12
x
|
Nbr of stocks (in thousands)
|
16,107
|
16,487
|
16,916
|
16,692
|
15,802
|
16,202
|
Reference price
2 |
6,720
|
19,650
|
18,300
|
12,850
|
8,870
|
9,010
|
Announcement Date
|
3/13/19
|
3/18/20
|
3/18/21
|
3/23/22
|
3/17/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
233,975
|
121,605
|
308,965
|
115,769
|
150,945
|
62,274
|
EBITDA
1 |
45,820
|
20,694
|
56,823
|
8,731
|
1,438
|
-30,278
|
EBIT
1 |
39,699
|
14,296
|
50,068
|
1,711
|
-5,127
|
-37,160
|
Operating Margin
|
16.97%
|
11.76%
|
16.21%
|
1.48%
|
-3.4%
|
-59.67%
|
Earnings before Tax (EBT)
1 |
34,198
|
16,022
|
42,615
|
427.2
|
-5,342
|
-41,871
|
Net income
1 |
29,834
|
11,152
|
33,459
|
761.8
|
-5,419
|
-37,407
|
Net margin
|
12.75%
|
9.17%
|
10.83%
|
0.66%
|
-3.59%
|
-60.07%
|
EPS
2 |
1,770
|
701.0
|
1,974
|
45.00
|
-339.1
|
-2,323
|
Free Cash Flow
1 |
35,954
|
19,198
|
69,902
|
23,605
|
-34,907
|
-7,812
|
FCF margin
|
15.37%
|
15.79%
|
22.62%
|
20.39%
|
-23.13%
|
-12.54%
|
FCF Conversion (EBITDA)
|
78.47%
|
92.77%
|
123.02%
|
270.36%
|
-
|
-
|
FCF Conversion (Net income)
|
120.51%
|
172.15%
|
208.92%
|
3,098.55%
|
-
|
-
|
Dividend per Share
2 |
150.0
|
150.0
|
350.0
|
200.0
|
100.0
|
-
|
Announcement Date
|
3/13/19
|
3/18/20
|
3/18/21
|
3/23/22
|
3/17/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
24,141
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,217
|
46,420
|
51,744
|
16,443
|
12,620
|
Leverage (Debt/EBITDA)
|
0.5269
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
35,954
|
19,198
|
69,902
|
23,605
|
-34,907
|
-7,812
|
ROE (net income / shareholders' equity)
|
22.5%
|
8.01%
|
20.5%
|
0.44%
|
-3.37%
|
-26.4%
|
ROA (Net income/ Total Assets)
|
11.6%
|
4.52%
|
14.3%
|
0.46%
|
-1.47%
|
-11.3%
|
Assets
1 |
256,987
|
246,508
|
233,557
|
166,007
|
368,134
|
331,823
|
Book Value Per Share
2 |
8,348
|
8,919
|
10,655
|
10,289
|
9,698
|
8,064
|
Cash Flow per Share
2 |
683.0
|
1,140
|
3,495
|
2,882
|
1,469
|
1,734
|
Capex
1 |
3,770
|
1,065
|
2,615
|
3,973
|
8,567
|
6,090
|
Capex / Sales
|
1.61%
|
0.88%
|
0.85%
|
3.43%
|
5.68%
|
9.78%
|
Announcement Date
|
3/13/19
|
3/18/20
|
3/18/21
|
3/23/22
|
3/17/23
|
3/21/24
|
|
1st Jan change
|
Capi.
|
---|
| -1.44% | 105M | | +21.32% | 161B | | +32.90% | 31.71B | | +23.80% | 31.29B | | -21.24% | 26.04B | | +29.83% | 23.39B | | -7.77% | 12.13B | | +118.80% | 9.41B | | +33.93% | 6.19B | | -21.45% | 4.94B |
Semiconductor Machinery Manufacturing
|